Category : Search result: IND enabling studies

Optigo Biotherapeutics Appoints Pharma Veteran Dr. Andreas Wallnofer to Board as Company Nears IND Milestone

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

04/11/2025 06:33

Unleashing the Monsters: UBC's New Course Explores Cinema's Most Terrifying Creatures

UBC's Monster Course: Exploring Cinema's Terrifying Creatures

Discover how UBC's groundbreaking course examines what makes cinematic monsters so compelling and what they reveal about our deepest fears and societal anxieties.

01/11/2025 09:27

Page 1 of 1

Category : Search result: IND enabling studies

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

UBC's Monster Course: Exploring Cinema's Terrifying Creatures

Toronto Condo Market Crashes: 53 Units Sold in September

Housing Crisis Fuels Domestic Violence in Calgary

Crown drops informant in Rosenfeldt murder trial